SG11201405149UA - Fraction i-iv-1 precipitation of immunoglobins from plasma - Google Patents

Fraction i-iv-1 precipitation of immunoglobins from plasma

Info

Publication number
SG11201405149UA
SG11201405149UA SG11201405149UA SG11201405149UA SG11201405149UA SG 11201405149U A SG11201405149U A SG 11201405149UA SG 11201405149U A SG11201405149U A SG 11201405149UA SG 11201405149U A SG11201405149U A SG 11201405149UA SG 11201405149U A SG11201405149U A SG 11201405149UA
Authority
SG
Singapore
Prior art keywords
immunoglobins
precipitation
fraction
plasma
Prior art date
Application number
SG11201405149UA
Other languages
English (en)
Inventor
Leopold Bruckschwaiger
Thomas Gundinger
Julia Nuernberger
Wolfgang Teschner
Hans-Peter Schwarz
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47833446&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201405149U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of SG11201405149UA publication Critical patent/SG11201405149UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/145Extraction; Separation; Purification by extraction or solubilisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201405149UA 2012-02-23 2013-02-25 Fraction i-iv-1 precipitation of immunoglobins from plasma SG11201405149UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261602488P 2012-02-23 2012-02-23
PCT/US2013/027681 WO2013126904A1 (en) 2012-02-23 2013-02-25 Fraction i-iv-1 precipitation of immunoglobins from plasma

Publications (1)

Publication Number Publication Date
SG11201405149UA true SG11201405149UA (en) 2014-09-26

Family

ID=47833446

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405149UA SG11201405149UA (en) 2012-02-23 2013-02-25 Fraction i-iv-1 precipitation of immunoglobins from plasma

Country Status (26)

Country Link
US (1) US9782477B2 (ja)
EP (2) EP2817334B1 (ja)
JP (1) JP6291423B2 (ja)
KR (1) KR101930582B1 (ja)
CN (1) CN104245730B (ja)
AR (1) AR090425A1 (ja)
AU (1) AU2013203112B2 (ja)
BR (1) BR112014020602B1 (ja)
CA (1) CA2864715A1 (ja)
CL (1) CL2014002225A1 (ja)
CO (1) CO7081143A2 (ja)
DK (1) DK2817334T3 (ja)
EA (1) EA032478B1 (ja)
ES (1) ES2928954T3 (ja)
HK (1) HK1205520A1 (ja)
HU (1) HUE060195T2 (ja)
IL (1) IL234103B (ja)
MX (2) MX365236B (ja)
MY (1) MY167235A (ja)
NZ (1) NZ628529A (ja)
PL (1) PL2817334T3 (ja)
PT (1) PT2817334T (ja)
SG (1) SG11201405149UA (ja)
SI (1) SI2817334T1 (ja)
TW (1) TWI629283B (ja)
WO (1) WO2013126904A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
CN104004091B (zh) * 2014-06-12 2016-08-17 新疆德源生物工程有限公司 一种人免疫球蛋白的制备工艺
CN104004090A (zh) * 2014-06-12 2014-08-27 新疆德源生物工程有限公司 一种人免疫球蛋白的制备方法
GB201413227D0 (en) * 2014-07-25 2014-09-10 Bioproducts Lab Ltd Process
ES2887588T3 (es) * 2015-08-13 2021-12-23 Kamada Ltd Composiciones derivadas de pasta de fracción de Cohn y uso de las mismas
CN108163898B (zh) * 2018-01-23 2020-12-04 中国科学院上海高等研究院 一种自调节铁氧体材料及其制备方法和应用
WO2022071990A1 (en) * 2020-04-10 2022-04-07 Plasma Technologies, Llc Compositions and methods for simplified high efficiency isolation of proteins
CN116322920A (zh) * 2020-11-09 2023-06-23 武田药品工业株式会社 使用氧化硅吸附从血浆中纯化fviii
CN112250757A (zh) * 2020-11-13 2021-01-22 广东深蓝生物科技有限公司 一种猪血浆中蛋白质的提取纯化方法
CA3203540A1 (en) * 2020-12-28 2022-07-07 Eugene ZURLO Systems and methods for process scale isolation of immunoglobulin g

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (ja) 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
US3998946A (en) 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
US4136094A (en) 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
US4499073A (en) 1981-08-24 1985-02-12 Cutter Laboratories, Inc. Intravenously injectable immune serum globulin
JPS5855432A (ja) * 1981-09-29 1983-04-01 Fujirebio Inc 静脈注射用免疫グロブリンの製法
DK166763C (da) 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
US6284874B1 (en) 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5616693A (en) 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
TW491855B (en) 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
US6124437A (en) 1997-03-19 2000-09-26 Welfide Corporation Immunoglobulin preparation and preparation process thereof
GB9705810D0 (en) * 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
EP0911037B2 (en) 1997-10-23 2007-06-13 Mitsubishi Pharma Corporation Room temperature storable immunoglobulin preparation for intravenous injection
SE0001128D0 (sv) 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
FR2824568B1 (fr) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
EP1413860A4 (en) * 2001-07-05 2009-02-25 Hamamatsu Photonics Kk SPECTROSCOPIC DEVICE
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
DK1664123T4 (da) 2003-09-22 2012-03-05 Kamada Ltd Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf
JP2008500959A (ja) 2004-01-30 2008-01-17 スオメン プナイネン リスティ ヴェリパルヴェル ウイルスについて安全な免疫グロブリンの製造方法
EP1718675B2 (en) 2004-02-27 2017-01-25 Octapharma AG A method of providing a purified, virus safe antibody preparation
US7807435B2 (en) 2005-08-11 2010-10-05 Baxter International Inc. Method for the purification of alpha-1 proteinase inhibitor (a1PI)
ES2595059T3 (es) 2007-03-20 2016-12-27 Csl Behring Gmbh Métodos para la producción a escala industrial de preparados terapéuticos del Factor H del complemento a partir de plasma humano
MX2011012576A (es) * 2009-05-27 2012-05-08 Baxter Int Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo.
WO2011011753A1 (en) 2009-07-23 2011-01-27 Baxter International Inc. Manufacture of factor h (fh) and fh-derivatives from plasma
AU2010202125B1 (en) * 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
WO2011150284A2 (en) * 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
SG187599A1 (en) 2010-07-23 2013-03-28 Baxter Int Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma

Also Published As

Publication number Publication date
CN104245730A (zh) 2014-12-24
TW201348248A (zh) 2013-12-01
SI2817334T1 (sl) 2022-11-30
AR090425A1 (es) 2014-11-12
IL234103B (en) 2019-11-28
JP2015509506A (ja) 2015-03-30
MX2014010076A (es) 2014-09-22
MY167235A (en) 2018-08-14
NZ628529A (en) 2016-09-30
EP2817334A1 (en) 2014-12-31
EP4119574A1 (en) 2023-01-18
CL2014002225A1 (es) 2015-01-16
EA201491564A1 (ru) 2015-04-30
KR101930582B1 (ko) 2018-12-18
TWI629283B (zh) 2018-07-11
MX365236B (es) 2019-05-28
HUE060195T2 (hu) 2023-02-28
JP6291423B2 (ja) 2018-03-14
MX2019005999A (es) 2019-08-21
CO7081143A2 (es) 2014-10-10
CA2864715A1 (en) 2013-08-29
DK2817334T3 (da) 2022-10-03
PL2817334T3 (pl) 2022-11-21
AU2013203112B2 (en) 2016-03-10
BR112014020602A2 (pt) 2018-09-11
CN104245730B (zh) 2017-09-01
EA032478B1 (ru) 2019-06-28
WO2013126904A1 (en) 2013-08-29
PT2817334T (pt) 2022-10-17
HK1205520A1 (en) 2015-12-18
IL234103A0 (en) 2014-09-30
US20130224183A1 (en) 2013-08-29
ES2928954T3 (es) 2022-11-23
BR112014020602B1 (pt) 2022-12-20
AU2013203112A1 (en) 2013-09-12
EP2817334B1 (en) 2022-09-21
KR20140135996A (ko) 2014-11-27
US9782477B2 (en) 2017-10-10

Similar Documents

Publication Publication Date Title
HK1245110B (zh) 異喹啉酮的固體形式
HK1205520A1 (en) Fraction i-iv-1 precipitation of immunoglobins from plasma i-iv-1
HK1210210A1 (en) Purification of virus like particles
HK1197063A1 (en) Heterocyclyl aminoimidazopyridazines
GB201423360D0 (en) Adaptive clustering of locations
EP2813073A4 (en) ADAPTIVE TARGET
PL3034498T3 (pl) Związki pośrednie dla funkcjonalnych polimerów Pla-Peg
HK1209767A1 (en) Purification of iduronate-2-sulfatase -2-
EP2786300A4 (en) PROTECTION OF ENTRIES AGAINST MALWARE SOFTWARE
HRP20160719T1 (hr) Sastav plazme bogate trombocitima
SG10201510800PA (en) Purification of flaviviruses
EP2707598A4 (en) PLASMA MICRO-THRUSTER
HRP20171309T1 (hr) Sublingvalna primjena statina
GB201217712D0 (en) methods of plasma etching
IL237862A0 (en) Methods to reduce the formation of scale
EP2892529A4 (en) USES OF (-) - PERHEXILINE
PL2733011T3 (pl) Osprzęt sieci trakcyjnej
EP2790506A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING TRANSCRIPTION OF IMMUNODEFICIENCY VIRUS
GB201609028D0 (en) Adaptive clustering of locations
AU346156S (en) Plasma gun
AU345774S (en) Plasma gun
GB201208707D0 (en) Processing of asphaltenes
GB201208369D0 (en) Plasma crucible sealing
GB201013522D0 (en) Chemotherapy of viruses
HK1170114A2 (en) One type of range hood